187 related articles for article (PubMed ID: 15868632)
1. Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease.
Levy DM; Silverman ED; Massicotte MP; McCrindle BW; Yeung RS
J Rheumatol; 2005 May; 32(5):928-34. PubMed ID: 15868632
[TBL] [Abstract][Full Text] [Related]
2. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease].
Suda K; Kudo Y; Sugawara Y; Ishii M; Matsuishi T
Nihon Rinsho; 2008 Feb; 66(2):355-9. PubMed ID: 18265459
[TBL] [Abstract][Full Text] [Related]
4. Warfarin-related outcomes in patients with antiphospholipid antibody syndrome managed in an anticoagulation clinic.
Wittkowsky AK; Downing J; Blackburn J; Nutescu E
Thromb Haemost; 2006 Aug; 96(2):137-41. PubMed ID: 16894455
[TBL] [Abstract][Full Text] [Related]
5. Progressive Coronary Dilatation Predicts Worse Outcome in Kawasaki Disease.
Chih WL; Wu PY; Sun LC; Lin MT; Wang JK; Wu MH
J Pediatr; 2016 Apr; 171():78-82.e1. PubMed ID: 26852179
[TBL] [Abstract][Full Text] [Related]
6. Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease.
Tsuda E; Arakaki Y; Shimizu T; Sakaguchi H; Yoshimura S; Yazaki S; Echigo S
Cardiol Young; 2005 Oct; 15(5):481-8. PubMed ID: 16164786
[TBL] [Abstract][Full Text] [Related]
7. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of giant coronary artery aneurysm secondary to Kawasaki disease.
Gu C; Fan S; Zhou H; Wang Y; Yi D; Zhao R; Sun G
Heart Surg Forum; 2009 Aug; 12(4):E241-3. PubMed ID: 19683998
[TBL] [Abstract][Full Text] [Related]
9. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
[TBL] [Abstract][Full Text] [Related]
10. [The probability of Kawasaki diseases in young patients with cardiac disorders--retrospective studies].
Pośnik-Urbańska A; Szymanowska Z; Kawecka-Jaszcz K
Przegl Lek; 2003; 60(12):792-6. PubMed ID: 15058018
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy.
Varkarakis IM; Rais-Bahrami S; Allaf ME; Lima GC; Permpongkosol S; Rao P; Jarrett TW; Kavoussi LR
J Urol; 2005 Sep; 174(3):1020-3; discussion 1023. PubMed ID: 16094036
[TBL] [Abstract][Full Text] [Related]
12. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
Poon IO; Lal L; Brown EN; Braun UK
J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
[TBL] [Abstract][Full Text] [Related]
13. Infections and Kawasaki disease: implications for coronary artery outcome.
Benseler SM; McCrindle BW; Silverman ED; Tyrrell PN; Wong J; Yeung RS
Pediatrics; 2005 Dec; 116(6):e760-6. PubMed ID: 16322132
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid treatment of refractory Kawasaki disease.
Lang BA; Yeung RS; Oen KG; Malleson PN; Huber AM; Riley M; Ebbeson R; Ramsey SE; Laxer RM; Silverman ED; McCrindle BW; Ratnapalan S; Feldman BM
J Rheumatol; 2006 Apr; 33(4):803-9. PubMed ID: 16583481
[TBL] [Abstract][Full Text] [Related]
15. [Kawasaki disease in Mexican children].
Vizcaíno-Alarcón A; Arévalo-Salas A; Rodríguez-López AM; Sadowinski-Pine S
Bol Med Hosp Infant Mex; 1991 Jun; 48(6):398-408. PubMed ID: 1910554
[TBL] [Abstract][Full Text] [Related]
16. [Cardiovascular abnormalities in Kawasaki disease. An Italian prospective study].
Salice P; Pietrogrande MC; Barbier P; Ghiglia S; Laicini E; Fesslova V
Cardiologia; 1998 Dec; 43(12):1367-74. PubMed ID: 9988946
[TBL] [Abstract][Full Text] [Related]
17. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease.
Suda K; Kudo Y; Higaki T; Nomura Y; Miura M; Matsumura M; Ayusawa M; Ogawa S; Matsuishi T
Circ J; 2009 Jul; 73(7):1319-23. PubMed ID: 19436123
[TBL] [Abstract][Full Text] [Related]
18. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease.
Tsuda E; Hamaoka K; Suzuki H; Sakazaki H; Murakami Y; Nakagawa M; Takasugi H; Yoshibayashi M
Am Heart J; 2014 Feb; 167(2):249-58. PubMed ID: 24439987
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
[TBL] [Abstract][Full Text] [Related]
20. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial.
Manlhiot C; Newburger JW; Low T; Dahdah N; Mackie AS; Raghuveer G; Giglia TM; Dallaire F; Mathew M; Runeckles K; Pahl E; Harahsheh AS; Norozi K; de Ferranti SD; Friedman K; Yetman AT; Kutty S; Mondal T; McCrindle BW;
Can J Cardiol; 2020 Oct; 36(10):1598-1607. PubMed ID: 32621885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
